Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Jane Jooyun Kim, Ph.D.

TitleAssociate Professor of Health Decision Science
InstitutionHarvard School of Public Health
DepartmentHealth Policy and Management
AddressHarvard School of Public Health
718 Huntington Avenue
Boston MA 02115
Phone617/432-0095

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Soeteman DI, Kim JJ. Cost-effectiveness of psychotherapy for personality disorders: treatment recommendations and implementation. Expert Rev Pharmacoecon Outcomes Res. 2013 Feb; 13(1):73-81.
    View in: PubMed
  2. Kiatpongsan S, Campos NG, Kim JJ. Potential benefits of second-generation human papillomavirus vaccines. PLoS One. 2012; 7(11):e48426.
    View in: PubMed
  3. Sharma M, Bruni L, Diaz M, Castellsagué X, Sanjosé Sd, Bosch FX, Kim JJ. Using HPV prevalence to predict cervical cancer incidence. Int J Cancer. 2013 Apr 15; 132(8):1895-900.
    View in: PubMed
  4. Soeteman DI, Miller M, Kim JJ. Modeling the risks and benefits of depression treatment for children and young adults. Value Health. 2012 Jul-Aug; 15(5):724-9.
    View in: PubMed
  5. Kim JJ. Opportunities to improve cervical cancer screening in the United States. Milbank Q. 2012 Mar; 90(1):38-41.
    View in: PubMed
  6. Campos NG, Castle PE, Schiffman M, Kim JJ. Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study. Med Decis Making. 2012 May-Jun; 32(3):400-27.
    View in: PubMed
  7. Kim JJ. The role of cost-effectiveness in U.S. vaccination policy. N Engl J Med. 2011 Nov 10; 365(19):1760-1.
    View in: PubMed
  8. Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer. 2012 Jun 1; 130(11):2672-84.
    View in: PubMed
  9. Soeteman DI, Busschbach JJ, Verheul R, Hoomans T, Kim JJ. Cost-effective psychotherapy for personality disorders in the Netherlands: the value of further research and active implementation. Value Health. 2011 Mar-Apr; 14(2):229-39.
    View in: PubMed
  10. Kim JJ. Focus on research: weighing the benefits and costs of HPV vaccination of young men. N Engl J Med. 2011 Feb 3; 364(5):393-5.
    View in: PubMed
  11. Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M. Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. J Infect Dis. 2011 Mar 15; 203(6):823-7.
    View in: PubMed
  12. Kim JJ. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis. 2010 Dec; 10(12):845-52.
    View in: PubMed
  13. Soeteman DI, Verheul R, Meerman AM, Ziegler U, Rossum BV, Delimon J, Rijnierse P, Thunnissen M, Busschbach JJ, Kim JJ. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands. J Clin Psychiatry. 2011 Jan; 72(1):51-9.
    View in: PubMed
  14. Kim JJ, Ortendahl J, Goldie SJ. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Ann Intern Med. 2009 Oct 20; 151(8):538-45.
    View in: PubMed
  15. Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ. 2009; 339:b3884.
    View in: PubMed
  16. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008 Aug 21; 359(8):821-32.
    View in: PubMed
  17. Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ. Mathematical models of cervical cancer prevention in the Asia Pacific region. Vaccine. 2008 Aug 19; 26 Suppl 12:M17-29.
    View in: PubMed
  18. Kim JJ, Brisson M, Edmunds WJ, Goldie SJ. Modeling cervical cancer prevention in developed countries. Vaccine. 2008 Aug 19; 26 Suppl 10:K76-86.
    View in: PubMed
  19. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Vaccine. 2008 Jul 29; 26(32):4015-24.
    View in: PubMed
  20. Kim JJ, Andres-Beck B, Goldie SJ. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer. 2007 Nov 5; 97(9):1322-8.
    View in: PubMed
  21. Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine. 2007 Aug 14; 25(33):6257-70.
    View in: PubMed
  22. Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol. 2007 Jul 15; 166(2):137-50.
    View in: PubMed
  23. Kim JJ, Salomon JA, Weinstein MC, Goldie SJ. Packaging health services when resources are limited: the example of a cervical cancer screening visit. PLoS Med. 2006 Nov; 3(11):e434.
    View in: PubMed
  24. Goldie SJ, Kim JJ, Myers E. Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/164-70.
    View in: PubMed
  25. Kim JJ. Mathematical model of HPV provides insight into impacts of risk factors and vaccine. PLoS Med. 2006 May; 3(5):e164.
    View in: PubMed
  26. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst. 2005 Jun 15; 97(12):888-95.
    View in: PubMed
  27. Kim JJ, Leung GM, Woo PP, Goldie SJ. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health (Oxf). 2004 Jun; 26(2):130-7.
    View in: PubMed
  28. Goldie SJ, Kim JJ, Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004 Apr; 103(4):619-31.
    View in: PubMed
  29. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002 May 8; 287(18):2382-90.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).
Kim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_